2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Oral Oncology
Oral oncology encompasses the study and treatment of cancers affecting the mouth, throat, and surrounding areas. In cancer research, understanding the complexities of oral oncology is crucial for developing targeted therapies and improving patient outcomes. Researchers investigate various aspects, including the role of genetic mutations, environmental factors like tobacco and alcohol use, and the impact of human papillomavirus (HPV) infections. Advances in molecular biology have led to the identification of specific biomarkers and signaling pathways implicated in oral cancers, paving the way for personalized treatment approaches. Additionally, ongoing studies explore innovative treatment modalities such as immunotherapy and targeted drug delivery systems to enhance efficacy and minimize side effects. Through interdisciplinary collaboration and cutting-edge research, the field of oral oncology continues to progress, offering hope for better prevention, diagnosis, and treatment of these complex diseases.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China